newsfilter
← Latest News
PR Newswire·

BIOVAXYS RETAINS MAXIM GROUP AS FINANCIAL ADVISOR AND INVESTMENT BANKER

VANCOUVER, British Columbia, April 17, 2023 /CNW/ -- BioVaxys Technology Corp. (CSE:BIOV) (FRA: 5LB) (OTCQB:BVAXF) ("BioVaxys" or "Company") is pleased to announce that it has retained New York City-based